Skip to content
10-Q

Quarterly Report

Relmada Therapeutics, Inc. RLMD

0001213900-25-073073

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 4, 2025 33.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 33.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 31.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 30.17M sh
Shares Diluted Q2 2025 · Jun 30, 2024 30.15M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$24.47M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$26.3M
Short Term Investments Q2 2025 · Jun 30, 2025 $19.27M
Short Term Investments Q2 2025 · Dec 31, 2024 $41.05M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.35M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.86M
Stockholders Equity Q2 2025 · Jun 30, 2025 $15.95M
Stockholders Equity Q2 2025 · Mar 31, 2025 $22.44M
Stockholders Equity Q2 2025 · Dec 31, 2024 $35.52M
Stockholders Equity Q2 2025 · Jun 30, 2024 $61.49M
Stockholders Equity Q2 2025 · Mar 31, 2024 $72.05M
Stockholders Equity Q2 2025 · Dec 31, 2023 $85.36M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.13M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.29M
Total Liabilities Q2 2025 · Jun 30, 2025 $5.17M
Total Liabilities Q2 2025 · Dec 31, 2024 $10.3M
Current Assets Q2 2025 · Jun 30, 2025 $21.09M
Current Assets Q2 2025 · Dec 31, 2024 $45.8M
Total Assets Q2 2025 · Jun 30, 2025 $21.12M
Total Assets Q2 2025 · Dec 31, 2024 $45.82M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.30
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.86
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.59
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.31
Eps Basic Q2 2025 · Jun 30, 2025 −$0.30
Eps Basic Q2 2025 · Jun 30, 2025 −$0.86
Eps Basic Q2 2025 · Jun 30, 2024 −$0.59
Eps Basic Q2 2025 · Jun 30, 2024 −$1.31
Sga Expense Q2 2025 · Jun 30, 2025 $7.4M
Sga Expense Q2 2025 · Jun 30, 2025 $13.67M
Sga Expense Q2 2025 · Jun 30, 2024 $8.1M
Sga Expense Q2 2025 · Jun 30, 2024 $17.78M
Rd Expense Q2 2025 · Jun 30, 2025 $2.82M
Rd Expense Q2 2025 · Jun 30, 2025 $14.77M
Rd Expense Q2 2025 · Jun 30, 2024 $10.72M
Rd Expense Q2 2025 · Jun 30, 2024 $24.03M
Net Income Q2 2025 · Jun 30, 2025 −$9.87M
Net Income Q2 2025 · Jun 30, 2025 −$27.43M
Net Income Q2 2025 · Mar 31, 2025 −$17.56M
Net Income Q2 2025 · Jun 30, 2024 −$17.77M
Net Income Q2 2025 · Jun 30, 2024 −$39.6M
Net Income Q2 2025 · Mar 31, 2024 −$21.83M
Operating Income Q2 2025 · Jun 30, 2025 −$10.22M
Operating Income Q2 2025 · Jun 30, 2025 −$28.44M
Operating Income Q2 2025 · Jun 30, 2024 −$18.82M
Operating Income Q2 2025 · Jun 30, 2024 −$41.81M